2018 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
December 10, 2018
Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
November 29, 2018
Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies
November 19, 2018
Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference
November 07, 2018
Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights
November 07, 2018
Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinson’s Disease
October 31, 2018
Voyager Therapeutics to Host Third Quarter 2018 Financial Results and Corporate Highlights Conference Call
October 16, 2018
Voyager Therapeutics Announces Preclinical Data for Huntington’s Disease and Amyotrophic Lateral Sclerosis Programs at the Congress of the European Society of Gene and Cell Therapy
August 28, 2018
Voyager Therapeutics to Present at Investor Conferences in September
August 07, 2018
Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights
August 02, 2018
Voyager Therapeutics to Present at Investor Conferences in August
July 31, 2018
Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights Conference Call
July 17, 2018
Voyager Therapeutics Receives FDA Guidance on Development Path for VY-AADC for Parkinson’s Disease and Provides Clinical Update
June 28, 2018
Voyager Therapeutics Appoints Andre Turenne as President and Chief Executive Officer
June 21, 2018
Voyager Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for VY-AADC for the Treatment of Parkinson’s Disease
May 29, 2018
Voyager Therapeutics Announces Management Change
May 18, 2018
Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting
May 17, 2018
Voyager Therapeutics Announces New Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting
May 10, 2018
Voyager Therapeutics Announces First Quarter 2018 Financial Results and Corporate Highlights
April 30, 2018
Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2018 Annual Meeting
March 14, 2018
Voyager Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
March 09, 2018
Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinson’s Disease
February 27, 2018
Voyager Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results and Corporate Highlights Conference Call
February 26, 2018
Voyager Therapeutics to Present at Cowen Health Care Conference
February 20, 2018
Voyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases
February 07, 2018
Voyager Therapeutics to Present at Leerink Partners Annual Global Healthcare Conference
January 31, 2018
Voyager Therapeutics Announces CEO Succession Plan for 2018
January 23, 2018
Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinson’s Disease